Avastin bevacizumab: Completed Phase II enrollment

Roche disclosed that last quarter its Genentech unit completed enrollment of 100 patients in the placebo-controlled Phase II AMBER trial evaluating Velcade bortezomib with or without 15 mg/kg IV Avas...